

A practical guide for providers: 5 steps to help patients find and fill Ryaltris prescriptions, plus alternatives and workflow tips for allergy season.
You've made the clinical decision to prescribe Ryaltris for your patient's seasonal allergic rhinitis. The combination of Olopatadine and Mometasone in a single nasal spray offers clear advantages — fast-acting antihistamine relief plus sustained anti-inflammatory action, better taste tolerability than Azelastine-based alternatives, and improved adherence through single-device convenience.
But if the patient can't find it at their pharmacy, none of that matters.
This guide provides actionable steps you can take — at the point of prescribing and within your practice workflow — to maximize the chance that your patients successfully fill their Ryaltris prescriptions.
Ryaltris (Olopatadine Hydrochloride 665 mcg / Mometasone Furoate 25 mcg per spray) has been commercially available in the U.S. since August 2022. As of 2026:
The challenge isn't that Ryaltris doesn't exist on pharmacy shelves — it's that it doesn't exist on enough pharmacy shelves at the times patients need it most.
Understanding the root causes helps you address them proactively:
With no generic manufacturers, Ryaltris inventory is entirely dependent on Hikma's production and distribution. Any lag in the supply chain — even minor ones — can cause localized stock-outs with no alternative source to fill the gap.
Large pharmacy chains (CVS, Walgreens, Rite Aid) use automated par-level systems that adjust inventory based on dispensing volume. For a brand-name product with relatively lower volume compared to generics, this means many locations don't maintain consistent stock. A pharmacy that fills two Ryaltris prescriptions per month may not keep any bottles on the shelf between fills.
Prior authorization requirements and step therapy protocols reduce the number of Ryaltris prescriptions that pharmacies fill, which in turn reduces the incentive for pharmacies to stock it. This creates a circular problem: low stock leads to unfilled prescriptions, which leads to lower dispensing volume, which leads to even lower stock levels.
Ryaltris is indicated for seasonal allergic rhinitis. Prescribing volume concentrates heavily in March–May and September–November. Pharmacies that carry zero or one bottle during off-season months face sudden spikes they can't easily accommodate.
The single most impactful thing you can do is verify that Ryaltris is available at the patient's preferred pharmacy before they leave your office. Use Medfinder for Providers to check real-time stock at pharmacies near the patient's home or work.
If the preferred pharmacy doesn't have it, you can:
This single step can prevent the majority of "I couldn't find it" callbacks.
Where you send the prescription matters. Consider these strategies:
Cost-related fill failures are common with brand-name medications. Address this proactively:
Handing patients a printed savings card or texting them the link before they leave your office significantly increases fill rates.
Many insurance plans require prior authorization for Ryaltris. Streamline the process by:
Pre-populating your PA templates with this language can reduce turnaround time and approval denials.
For every Ryaltris prescription, consider having a pre-determined alternative on file. This way, if the pharmacy can't fill Ryaltris and the patient calls back, your staff can quickly pivot:
When Ryaltris is unavailable or cost-prohibitive, these alternatives provide comparable clinical benefit:
For a patient-facing comparison of alternatives, share our guide: alternatives to Ryaltris.
Integrate these practices into your allergy season workflow:
Prescribing Ryaltris is the easy part. Getting it into your patients' hands requires navigating a landscape of inventory gaps, insurance hurdles, and cost barriers. By checking availability before prescribing, providing savings resources, preparing for prior authorizations, and having backup alternatives ready, you can dramatically reduce fill failures and improve patient satisfaction.
Tools like Medfinder for Providers make this process faster and more reliable. The goal is straightforward: when you prescribe Ryaltris, your patient should be able to fill it — the same day, at a price they can afford.
For more provider resources, see our Ryaltris shortage briefing for providers and how to help patients save money on Ryaltris.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.